Plasmonic Nanoparticle-based Digital Cytometry to Quantify MUC16 Binding on the Surface of Leukocytes in Ovarian Cancer
Sierra Research’s team has developed the algorithms that lead to the data of the following article: https://pubs.acs.org/doi/abs/10.1021/acssensors.0c00567 Plasmonic nanoparticles conjugated with anti-CA125 antibody were used to quantify MUC16 binding on leukocytes of ovarian cancer patients. Results show an elevated presence of MUC16 on ovarian cnacer patients with respect to healthy controls. Further, the assay was…